GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (OTCPK:HNSPF) » Definitions » Marketable Securities

Hansoh Pharmaceutical Group Co (Hansoh Pharmaceutical Group Co) Marketable Securities : $339 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Hansoh Pharmaceutical Group Co's Marketable Securities for the quarter that ended in Dec. 2023 was $339 Mil.

Hansoh Pharmaceutical Group Co's annual Marketable Securities declined from Dec. 2021 ($664 Mil) to Dec. 2022 ($575 Mil) and declined from Dec. 2022 ($575 Mil) to Dec. 2023 ($339 Mil).

Hansoh Pharmaceutical Group Co Marketable Securities Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Marketable Securities Chart

Hansoh Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial 906.16 1,442.47 664.28 574.92 339.26

Hansoh Pharmaceutical Group Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 664.28 592.62 574.92 924.25 339.26

Hansoh Pharmaceutical Group Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Hansoh Pharmaceutical Group Co  (OTCPK:HNSPF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Hansoh Pharmaceutical Group Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansoh Pharmaceutical Group Co (Hansoh Pharmaceutical Group Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (OTCPK:HNSPF) » Definitions » Marketable Securities
Comparable Companies
HKSE:00867 HKSE:03320 HKSE:00570 HKSE:02096 HKSE:00512 HKSE:03933 HKSE:06185 HKSE:02005 HKSE:03613 HKSE:01349 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ NSE:DIVISLAB
Traded in Other Exchanges
03692:Hong Kong
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Website
https://www.hspharm.com
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (Hansoh Pharmaceutical Group Co) Headlines

No Headlines